FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Peter Häusler

Research Profile

Chemicals & Drugs

Disorders

Physiology

Gene Expression Regulation, Neoplastic

Concepts & Ideas

Procedures

Living Beings

Heterozygote

Co-author Network

Publications

TOP 3
André B P van Kuilenburg; Detlev Behnke; Peter Häusler; Kati Jabschinsky; Johannes H Proost; Andreas Schalhorn; Wolfgang Schwabe; Michael W T Tanck; Christoph Terborg; Jan Gerard Maring
Evaluation of 5-fluorouracil pharmacokinetics in cancer patients with a c.1905+1G>A mutation in DPYD by means of a Bayesian limited sampling strategy.
Torsten Liersch; Claus Langer; B Michael Ghadimi; Bettina Kulle; Daniela E Aust; Gustavo B Baretton; Wolfgang Schwabe; Peter Häusler; Heinz Becker; Christiane Jakob
Lymph node status and TS gene expression are prognostic markers in stage II/III rectal cancer after neoadjuvant fluorouracil-based chemoradiotherapy.
Christiane Jakob; Torsten Liersch; Wolfdietrich Meyer; Gustavo B Baretton; Wolfgang Schwabe; Peter Häusler; Bettina Kulle; Heinz Becker; Daniela E Aust
Prognostic value of histologic tumor regression, thymidylate synthase, thymidine phosphorylase, and dihydropyrimidine dehydrogenase in rectal cancer UICC Stage II/III after neoadjuvant chemoradiotherapy.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Peter Häusler (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: André B P van Kuilenburg; Detlev Behnke; Peter Häusler; Kati Jabschinsky; Johannes H Proost; Andreas Schalhorn; Wolfgang Schwabe; Michael W T Tanck; Christoph Terborg; Jan Gerard Maring
Evaluation of 5-fluorouracil pharmacokinetics in cancer patients with a c.1905+1G>A mutation in DPYD by means of a Bayesian limited sampling strategy.
Clinical pharmacokinetics 2012;51(3):163-74.
2006: Torsten Liersch; Claus Langer; B Michael Ghadimi; Bettina Kulle; Daniela E Aust; Gustavo B Baretton; Wolfgang Schwabe; Peter Häusler; Heinz Becker; Christiane Jakob
Lymph node status and TS gene expression are prognostic markers in stage II/III rectal cancer after neoadjuvant fluorouracil-based chemoradiotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(25):4062-8.
2006: Christiane Jakob; Torsten Liersch; Wolfdietrich Meyer; Gustavo B Baretton; Wolfgang Schwabe; Peter Häusler; Bettina Kulle; Heinz Becker; Daniela E Aust
Prognostic value of histologic tumor regression, thymidylate synthase, thymidine phosphorylase, and dihydropyrimidine dehydrogenase in rectal cancer UICC Stage II/III after neoadjuvant chemoradiotherapy.
The American journal of surgical pathology 2006;30(9):1169-74.
2005: Christiane Jakob; Torsten Liersch; Wolfdietrich Meyer; Gustavo B Baretton; Peter Häusler; Wolfgang Schwabe; Heinz Becker; Daniela E Aust
Immunohistochemical analysis of thymidylate synthase, thymidine phosphorylase, and dihydropyrimidine dehydrogenase in rectal cancer (cUICC II/III): correlation with histopathologic tumor regression after 5-fluorouracil-based long-term neoadjuvant chemoradiotherapy.
The American journal of surgical pathology 2005;29(10):1304-9.
2004: Christiane Jakob; Daniela E Aust; Wolfdietrich Meyer; Gustavo B Baretton; Wolfgang Schwabe; Peter Häusler; Heinz Becker; Torsten Liersch
Thymidylate synthase, thymidine phosphorylase, dihydropyrimidine dehydrogenase expression, and histological tumour regression after 5-FU-based neo-adjuvant chemoradiotherapy in rectal cancer.
The Journal of pathology 2004;204(5):562-8.
2004: Thomas Ihmann; Jian Liu; Wolfgang Schwabe; Peter Häusler; Detlev Behnke; Hans-Peter Bruch; Rainer Broll; Ute Windhövel; Michael Duchrow
High-level mRNA quantification of proliferation marker pKi-67 is correlated with favorable prognosis in colorectal carcinoma.
Journal of cancer research and clinical oncology 2004;130(12):749-56.
2003: Marko Kornmann; Wolfgang Schwabe; Silvia Sander; Martina Kron; Jörn Sträter; Sucan Polat; Erika Kettner; Hans F Weiser; Wolfram Baumann; Harald Schramm; Peter Häusler; Kati Ott; Detlev Behnke; Ludger Staib; Hans G Beger; Karl-Heinrich Link
Thymidylate synthase and dihydropyrimidine dehydrogenase mRNA expression levels: predictors for survival in colorectal cancer patients receiving adjuvant 5-fluorouracil.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(11):4116-24.
2002: Marko Kornmann; Karl-Heinrich Link; Inga Galuba; Kati Ott; Wolfgang Schwabe; Peter Häusler; Peter Scholz; Jörn Sträter; Sucan Polat; Bernhard Leibl; Erika Kettner; Christoph Schlichting; Wolfram Baumann; Harald Schramm; Ute Hecker; Karsten Ridwelski; Jürgen H Vogt; Klaus-Ullrich Zerbian; Frank Schütze; Ernst D Kreuser; Detlev Behnke; Hans G Beger
Association of time to recurrence with thymidylate synthase and dihydropyrimidine dehydrogenase mRNA expression in stage II and III colorectal cancer.
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 2002;6(3):331-7.
2002: Martin Raida; Kay-Oliver Kliche; Wolfgang Schwabe; Peter Häusler; Joachim H Clement; Detlev Behnke; Klaus Höffken
Circadian variation of dihydropyrimidine dehydrogenase mRNA expression in leukocytes and serum cortisol levels in patients with advanced gastrointestinal carcinomas compared to healthy controls.
Journal of cancer research and clinical oncology 2002;128(2):96-102.
2001: Martin Raida; Wolfgang Schwabe; Peter Häusler; A B Van Kuilenburg; A H Van Gennip; Detlev Behnke; Klaus Höffken
Prevalence of a common point mutation in the dihydropyrimidine dehydrogenase (DPD) gene within the 5'-splice donor site of intron 14 in patients with severe 5-fluorouracil (5-FU)- related toxicity compared with controls.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(9):2832-9.